Clinical Trial Update: Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating the antiplatelet effect of Ginkgo diterpene lactone meglumine injection in acute ischemic stroke. Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ginkgo Diterpene Lactone Meglumine Injection (Ginkgo diterpene lactone meglumine)

Snippet

Sponsor: Shanghai Yueyang Integrated Medicine Hospital | Conditions: Ischemic Stroke | Phase 2, Phase 3 | Status: UNKNOWN